The development of new preventive measures and therapeutic methods in the management of hand-foot syndrome by multi-kinase inhibitors sorafenib.
Not Applicable
- Conditions
- Hepastocellular cancer(HCC)
- Registration Number
- JPRN-UMIN000032026
- Lead Sponsor
- ational Defense Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 16
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with fissure or erosion in the palmoplantar area 2) Patients with a history of sympathectomy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method